Search Press releases Keywords From To 4 Sep 2020 Disposals of own shares Read More 31 Aug 2020 Phase 3 data on VIMPAT[®] (lacosamide) in primary generalized tonic-clonic seizures published in Journal of Neurology, Neurosurgery & Psychiatry Read More 28 Aug 2020 Disposals of own shares Read More 21 Aug 2020 Disposals of own shares Read More 10 Aug 2020 Acquisitions and disposals of own shares Read More 5 Aug 2020 CIMZIA[®] is the First and Only Biologic Approved in Europe with the Option for a Reduced Maintenance Dose for Patients Across the Full Axial Spondyloarthritis Spectrum Read More Pagination First page Previous page Previous … Page 43 Page 44 Page 45 Page 46 Current page 47 Page 48 Page 49 Page 50 Page 51 … Next page Next Last page Stay up-to-date on the latest news and information from UCB Subscribe
